Mankind Pharma fundamental analysis
MANKIND
2089.3
73.30 (-3.39%)Last updated on 4 Feb, 2026 | 15:55 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Mankind Pharma Fundamentals
P/E Ratio
50.02
P/B Ratio
5.82
Div. Yield
0
Sector P/E
67.04
Sector P/B
1.38
Sec. Div. Yield
0.58
Mankind Pharma Fundamentals is currently trading with a P/E Ratio of 50.02, compared to the sector average of 67.04. Its P/B Ratio stands at 5.82, while the sector’s is 1.38. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.58%.
Mankind Pharma Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Mankind Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
